(R)-1-o-Tolylethanamine hydrochloride, 95.0%, 100mg

(S)-Benzyl (1-hydrazinyl-3-hydroxy-1-oxopropan-2-yl)carbamate, 95.0%, 5g

(2S)-2-AMINO-2-(3-CHLORO-4-FLUOROPHENYL)ETHAN-1-OL, 95.0%, 1g

2,3-Dichloro-4-nitrophenol, 95.0%, 100mg

Anti-GD3 Monoclonal Antibody1vial

3-(Chloromethyl)-2-fluoropyridine, 95.0%, 10g

2-Bromo-1-(1,4-dimethyl-1H-pyrazol-3-yl)ethanone, 97.0%, 250mg

2-Amino-3-(2-hydroxyphenyl)propanoic acid, 95.0%, 100mg

N1-(4,7-dimethoxybenzo[d]thiazol-2-yl)-N2,N2-diethylethane-1,2-diamine, 95.0%, 250mg

1,2,3,4-Tetrahydroquinolin-7-amine dihydrochloride, 97%, 10g

Fmoc-cis-2-aminocyclohexanecarboxylic acid, 99.0%, 5g

3-(4-Methylphenyl)-1,2-oxazole-5-carboxylic acid, 95%, 2.5g

Ethyl Glycidyl Ether>98.0%(GC)500mL